NICE inquiry hears evidence

The process of providing guidance and approving drugs for the NHS is flawed and needs more engagement with experts, the Commons health select committee has heard in evidence in its inquiry into the National Institute for Health and Clinical Excellence.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here